These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22228255)

  • 21. Pharmacogenetics of osteoporosis and the prospect of individualized prognosis and individualized therapy.
    Nguyen TV; Center JR; Eisman JA
    Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):481-8. PubMed ID: 18971675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Considerations for rare variants in drug metabolism genes and the clinical implications.
    Drögemöller BI; Wright GE; Warnich L
    Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):873-84. PubMed ID: 24673405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics: from bench to byte.
    Swen JJ; Wilting I; de Goede AL; Grandia L; Mulder H; Touw DJ; de Boer A; Conemans JM; Egberts TC; Klungel OH; Koopmans R; van der Weide J; Wilffert B; Guchelaar HJ; Deneer VH
    Clin Pharmacol Ther; 2008 May; 83(5):781-7. PubMed ID: 18253145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of the pharmacoeconomics of pharmacogenetics.
    Dervieux T; Bala MV
    Pharmacogenomics; 2006 Dec; 7(8):1175-84. PubMed ID: 17184205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Criteria for the selection of single nucleotide polymorphisms in pathway pharmacogenetics: TNF inhibitors as a case study.
    Kooloos WM; Wessels JA; van der Straaten T; Huizinga TW; Guchelaar HJ
    Drug Discov Today; 2009 Sep; 14(17-18):837-44. PubMed ID: 19524701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recursive partitioning analysis of complex disease pharmacogenetic studies. I. Motivation and overview.
    Young SS; Ge N
    Pharmacogenomics; 2005 Jan; 6(1):65-75. PubMed ID: 15723607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics.
    Schwarz UI; Gulilat M; Kim RB
    Cold Spring Harb Perspect Med; 2019 Feb; 9(2):. PubMed ID: 29844222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Data science approaches to pharmacogenetics.
    Penrod NM; Moore JH
    Curr Mol Med; 2014; 14(7):805-13. PubMed ID: 25109795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine pharmacogenomics: using the mouse to understand the genetics of drug therapy.
    Watters JW; McLeod HL
    Pharmacogenomics; 2002 Nov; 3(6):781-90. PubMed ID: 12437480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically relevant genetic variations in drug metabolizing enzymes.
    Pinto N; Dolan ME
    Curr Drug Metab; 2011 Jun; 12(5):487-97. PubMed ID: 21453273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacogenetics in pediatric patients.
    Husain A; Loehle JA; Hein DW
    Pharmacogenomics; 2007 Oct; 8(10):1403-11. PubMed ID: 17979513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetic biomarkers for predicting drug response.
    Bank PC; Swen JJ; Guchelaar HJ
    Expert Rev Mol Diagn; 2014 Jul; 14(6):723-35. PubMed ID: 24857685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment.
    Mroziewicz M; Tyndale RF
    Addict Sci Clin Pract; 2010 Dec; 5(2):17-29. PubMed ID: 22002450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Special report: pharmacogenomics of cancer-candidate genes.
    Technol Eval Cent Assess Program Exec Summ; 2007 Nov; 22(5):1-3. PubMed ID: 18080403
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical relevance of pharmacogenetics.
    Becquemont L
    Drug Metab Rev; 2003 Nov; 35(4):277-85. PubMed ID: 14705861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline oncopharmacogenetics, a promising field in cancer therapy.
    Pesenti C; Gusella M; Sirchia SM; Miozzo M
    Cell Oncol (Dordr); 2015 Feb; 38(1):65-89. PubMed ID: 25573079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.
    Brockmöller J; Tzvetkov MV
    Eur J Clin Pharmacol; 2008 Feb; 64(2):133-57. PubMed ID: 18224312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability.
    Zhou Y; Lauschke VM
    Clin Pharmacol Ther; 2021 Sep; 110(3):626-636. PubMed ID: 33998671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.